title: [Effect of exanguinotransfusion on the immune system of neonate].
abstract: Exanguinotransfusion is commonly used during therapeutic procedure in neonates with hyperbillirubinemia risking to cause brain injury of the neonate. This therapy without alternative may couse anemia, hyper or hypotonus, and behavior problems. Those disturbances are not clearly understood yet, but it appears that this process is mediated by the immune system. In order to confirm this hypothesis parallely with clinical examination, we performed the following laboratory investigations: red blood cell count, hemoglobin, hematocrite, white blood cells, natural killer cells, T lymphocyte subsets, ability of the peripheral blood phagocytes to reduce NBT, the phagocytic ability and hemiluminescent response. In the clinical examination the most common finding was hypertonus or hypotonus of the muscules. The values of hemoglobin and hematocrite were reduced, red blood cell count was similar, while the white blood cell particularly the monocyte count was increased compared to the control. The absolute number of T lymphocytes defined by CD2 and CD3 surface marker expression was depleted, while the number of DR positive cells as well as the number of NK cells was increased in group treated with exanguinotransfusion. We have also found an increase of NBT positive cells in the same group. There were no differences in the number of NBT positive cells, when they were prestimulated by PMA. Phagocytic ability was lower compared to the control, while hemiluminescent response was faster remaining on high level for a long time. All those differences remained for several months after exanguinotransfusion.
authors.forename: S
authors.initials: S
authors.lastname: Sbivić
authors.forename: B
authors.initials: B
authors.lastname: Kamenov
authors.forename: S
authors.initials: S
authors.lastname: Najman
authors.forename: J
authors.initials: J
authors.lastname: Vojinović
authors.forename: Lj
authors.initials: Lj
authors.lastname: Branković
authors.forename: H
authors.initials: H
authors.lastname: Dimitrijević
authors.forename: V
authors.initials: V
authors.lastname: Mitrović
authors.forename: S
authors.initials: S
authors.lastname: Maglajlić
mesh_terms: D005078:Exchange Transfusion, Whole Blood / Q000009:adverse effects*; D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000276:immunology* / Q000628:therapy; D007223:Infant; D007231:Infant, Newborn